Researcher Next
Create account
← Back to directory

Chong‐Jen Yu

Researcher Next ID · RN-014323

Researcher · Medicine

National Taiwan University Hospital

, Taiwan

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
959
Citation count
37,980
H-index
90
i10-index
508

Research interests

Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Diagnosis and Treatment
Lung Cancer Research Studies
Tuberculosis Research and Epidemiology
Mycobacterium research and diagnosis

Publications

  • Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2020 · 10.1056/nejmoa2027071

  • Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

    Journal of the American Society of Nephrology · 2020 · 10.1681/asn.2020030276

  • First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

    The Lancet · 2017 · 10.1016/s0140-6736(17)30123-x

  • Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00026-1

  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

    Proceedings of the National Academy of Sciences · 2007 · 10.1073/pnas.0710370104

Current projects

    No projects listed.